XNAS
SBRA
Market cap4.75bUSD
Oct 08, Last price
18.84USD
1D
0.53%
1Q
-3.98%
Jan 2017
-22.85%
IPO
-33.26%
Name
Sabra Health Care REIT Inc
Chart & performance
P/E
30.53
P/S
6.13
EPS
0.62
Div yield, %
6.37%
Shrs. gr., 5y
3.36%
Rev. gr., 5y
5.29%
Revenues
775m
+10.15%
Net income
156m
+22.81%
CFO
349m
+12.26%
Dividend
Aug 14, 20260.3 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Related entities
Subsidiaries (3)
SABRA CAPITAL CORPORATION
SABRA CANADIAN HOLDINGS, LLC
SABRA HEALTH CARE LIMITED PARTNERSHIP
Key people
Michael Costa
Chief Financial Officer, Executive Vice President, Secretary · since 2022
Darrin Smith
Executive Vice President, Chief Investment Officer, Treasurer · since 2026
Michael Foster
Lead Independent Director · since 2010
Richard Matros
Chairman of the Board, President, Chief Executive Officer · since 2010
Independent Director · since 2010
Katie Cusack
Independent Director · since 2021
Lynne Katzmann
Independent Director · since 2019
Independent Director · since 2020
Independent Director · since 2017
Legal address
C/O THE CORPORATION TRUST INCORPORATED
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093-2264
US
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093-2264
US
Headquarters
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093-2264
US
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093-2264
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||